Keywords: Pfizer, Label change, Tygacil, USA, FDA, Antibacterial

US FDA makes label change on Pfizer’s Tygacil to reflect increased mortality risk

Article | 06 September 2010

Print This

The US Food and Drug Administration has issued an alert reminded health care professionals of an increased mortality risk associated ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in